1 |
Retinoblastoma: A review of the molecular basis of tumor development and its clinical correlation in shaping future targeted treatment strategies |
|
|
| Shruti Rathore, Aman Verma, Ria Ratna, Navjot Marwa, Yagya Ghiya, Santosh G Honavar, Anil Tiwari, Sima Das, Akhil Varshney |
|
| Indian Journal of Ophthalmology. 2023; 71(7): 2662 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
2 |
Identification of Epigenetically Modified Hub Genes and Altered Pathways Associated With Retinoblastoma |
|
|
| Aditi Karmakar, Md. Maqsood Ahamad Khan, Nidhi Kumari, Nalini Devarajan, Senthil Kumar Ganesan |
|
| Frontiers in Cell and Developmental Biology. 2022; 10 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
3 |
An in Vivo Study of Intravitreal Ranibizumab Following Subretinal Inoculation of Rb Cells In Rabbits’ Eyes |
|
|
| Nor Azimah Abd Aziz, Diana Toh Shi Jin, Tengku Ain Fathlun Tengku Kamalden, Sarina Sulung, Khairy Shamel Sonny Teo, Azhany Yaakub, Nor Hayati Othman, Liza-Sharmini Ahmad Tajudin |
|
| Czech and Slovak Ophthalmology. 2022; 78(3): 112 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
4 |
CircCUL2 suppresses retinoblastoma cells by regulating miR-214-5p/E2F2 Axis |
|
|
| Hui Zhang, XinWen Qiu, ZhiJie Song, LiXia Lan, Xuan Ren, Bo Ye |
|
| Anti-Cancer Drugs. 2022; 33(1): e218 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
5 |
TRIB3 promotes proliferation, migration, and invasion of retinoblastoma cells by activating the AKT/mTOR signaling pathway |
|
|
| Xian-Yi Bao, Ming Sun, Ting-Ting Peng, Dong-Mei Han |
|
| Cancer Biomarkers. 2021; 31(4): 307 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
6 |
Intraocular Tumors—Advances in Ophthalmic Pathology |
|
|
| Sneha Giridhar, Dipankar Das, Jyotirmay Biswas |
|
| Advances in Ophthalmology and Optometry. 2021; 6: 133 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
7 |
Long non-coding RNA SND1-IT1 accelerates cell proliferation, invasion and migration via regulating miR-132-3p/SMAD2 axis in retinoblastoma |
|
|
| Dong-Fang Yin, Xue-Jun Zhou, Na Li, Hui-Jie Liu, Hu Yuan |
|
| Bioengineered. 2021; 12(1): 1189 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
8 |
Therapeutic Targeting PLK1 by ON-01910.Na Is Effective in Local Treatment of Retinoblastoma |
|
|
| Huan Ma, Cong Nie, Ying Chen, Jinmiao Li, Yanjie Xie, Zhixin Tang, Yang Gao, Siming Ai, Yuxiang Mao, Qian Sun, Rong Lu |
|
| Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics. 2021; 28(7): 745 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
9 |
Long non-coding RNA SNHG20 promotes cell proliferation, migration and invasion in retinoblastoma via the miR-335-5p/E2F3 axis |
|
|
| Jing Song, Ziping Zhang |
|
| Molecular Medicine Reports. 2021; 24(2) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
10 |
Retinoblastoma brachytherapy (literature review) |
|
|
| E. S. Kotova, A. A. Yarovoy, D. P. Volodin, A. V. Kotelnikova |
|
| Russian Journal of Pediatric Hematology and Oncology. 2021; 8(1): 50 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
11 |
Long non-coding RNA LEF1-AS1 is involved in the progression of retinoblastoma through regulating the Wnt/ß-catenin pathway |
|
|
| Hua He, Mu Qin |
|
| Clinical and Experimental Pharmacology and Physiology. 2020; 47(5): 886 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
12 |
Intra-Arterial Chemotherapy for Retinoblastoma: Four-Year Results from Tertiary Center in India |
|
|
| Pukhraj Rishi, Ashutosh Agarwal, Pritam Chatterjee, Tarun Sharma, Minal Sharma, Munusamy Saravanan, R. Ravikumar |
|
| Ocular Oncology and Pathology. 2020; 6(1): 66 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
13 |
Clinical relevance of the comparative expression of immune checkpoint markers with the clinicopathological findings in patients with primary and chemoreduced retinoblastoma |
|
|
| Lata Singh, Mithalesh Kumar Singh, Moshahid Alam Rizvi, Sameer Bakhshi, Rachna Meel, Neiwete Lomi, Seema Sen, Seema Kashyap |
|
| Cancer Immunology, Immunotherapy. 2020; 69(6): 1087 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
14 |
LncRNA TMPO-AS1 up-regulates the expression of HIF-1a and promotes the malignant phenotypes of retinoblastoma cells via sponging miR-199a-5p |
|
|
| Xifeng Peng, Jian Yan, Fang Cheng |
|
| Pathology - Research and Practice. 2020; 216(4): 152853 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
15 |
Gold nanoparticles in ophthalmology |
|
|
| Florence Masse, Mathieu Ouellette, Guillaume Lamoureux, Elodie Boisselier |
|
| Medicinal Research Reviews. 2019; 39(1): 302 |
|
| [Pubmed] [Google Scholar] [DOI] |
|
16 |
Comparison of ocular pharmacokinetics of etoposide and its nanoemulsion after subtenon administration in rabbits |
|
|
| Santosh Kumar Patnaik, Nabanita Halder, Bhavna Chawla, Deepti Maithani, Vasantha Thavaraj, Nihar Ranjan Biswas, Thirumurthy Velpandian |
|
| Journal of Basic and Clinical Physiology and Pharmacology. 2019; 30(5) |
|
| [Pubmed] [Google Scholar] [DOI] |
|
17 |
9.4T and 17.6T MRI of Retinoblastoma: Ex Vivo evaluation of microstructural anatomy and disease extent compared with histopathology |
|
|
| Marcus C. de Jong, Pim de Graaf, Petra J.W. Pouwels, Jan-Willem Beenakker, Robin W. Jansen, Jeroen J.G. Geurts, Annette C. Moll, Jonas A. Castelijns, Paul van der Valk, Louise van der Weerd |
|
| Journal of Magnetic Resonance Imaging. 2018; 47(6): 1487 |
|
| [Pubmed] [Google Scholar] [DOI] |
|